Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations

2022-03-17| In-DepthTrials & Approvals

Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations

by GeneOnline

Share To

Achieving market entry for new drugs has never been more challenging, especially for non-COVID medications during a time shrouded in COVID-19. Notably, the US FDA has pushed to accelerate the launches of non-COVID medications and has been reviewing more next-generation (Next-Gen) drugs in the last 14 months. Next-Gen drugs, here chiefly describing the first-in-class and regeneration ones which encompass strong clinical benefits and market competitions, are evolving fast year on year.

GO Prime with only $1.49 now

SUBSCRIBE NOW

LATEST

Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration

2025-03-21

European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1

2025-03-21

Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant

2025-03-21

Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders

2025-03-21

Trump Administration Policies May Impact Health Care for Intersex Individuals

2025-03-21

Federal Health Care Research Agency Faces Potential Mass Layoffs

2025-03-21

Police and Hospitals’ Drug Confiscation Practices Examined

2025-03-21

EVENT

2025-04-02

Asia Cell and Gene Therapy Innovation Summit 2025

Shanghai, China

2025-04-21

World Vaccine Congress Washington 2025

Washington, U.S.A

2025-04-21

World Vaccine Congress 2025

Washington, U.S.A

2025-04-25

AACR Annual Meeting 2025

Chicago, U.S.A

2025-04-26

SABPA OC/LA 17th Annual Biomedical Forum

Irvine, California, United States

2025-05-03

29th Taiwan Joint Cancer Conference 2025

Taipei, Taiwan

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog